Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of "Eustachian ridge?"
Mohammed QintarDee Dee WangWilliam W O'NeillBrian O'NeillPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2021)
Severe symptomatic tricuspid regurgitation (TR) remains an undertreated disease. Multiple trans-catheter treatment options are currently under investigation. Transcatheter caval valve implantation (CAVI) has been utilized as a treatment option and aims at decreasing or eliminating the caval backflow that occurs in severe TR patients. Understanding challenges with this therapy is paramount. Hereby we present a CAVI case with resultant non-coaptation of valve leaflets in a patient with a prominent Eustachian ridge.
Keyphrases
- aortic valve
- aortic stenosis
- ejection fraction
- mitral valve
- transcatheter aortic valve replacement
- inferior vena cava
- early onset
- vena cava
- end stage renal disease
- left ventricular
- newly diagnosed
- chronic kidney disease
- prognostic factors
- coronary artery disease
- drug induced
- peritoneal dialysis
- pulmonary embolism
- case report
- heart failure
- mesenchymal stem cells
- replacement therapy